He Y - Search Results

1

miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.

Zhang X, Dong J, He Y, Zhao M, Liu Z, Wang N, Jiang M, Zhang Z, Liu G, Liu H, Nie Y, Fan D, Tie J. Zhang X, et al. Among authors: he y. Gene. 2017 Jun 5;615:42-49. doi: 10.1016/j.gene.2017.03.022. Epub 2017 Mar 18. Gene. 2017. PMID: 28323002

2

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T. Kong X, et al. Among authors: he y. PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876288 Free PMC article.

3

Prognostic potential of miR-144 in various cancers: A meta-analysis.

Jia CY, He Y, Wu SN, He YT, Wang Y. Jia CY, et al. Among authors: he y, he yt. Medicine (Baltimore). 2022 Nov 18;101(46):e31728. doi: 10.1097/MD.0000000000031728. Medicine (Baltimore). 2022. PMID: 36401491 Free PMC article.

4

MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer.

Xu H, He Y, Lin L, Li M, Zhou Z, Yang Y. Xu H, et al. Among authors: he y. Biochem Biophys Res Commun. 2021 Oct 20;575:56-64. doi: 10.1016/j.bbrc.2021.08.037. Epub 2021 Aug 15. Biochem Biophys Res Commun. 2021. PMID: 34461437

5

Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis.

Cai T, Peng B, Hu J, He Y. Cai T, et al. Among authors: he y. Bioengineered. 2022 May;13(5):13407-13421. doi: 10.1080/21655979.2022.2072629. Bioengineered. 2022. PMID: 36700475 Free PMC article.

6

MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.

Zhang LY, Chen Y, Jia J, Zhu X, He Y, Wu LM. Zhang LY, et al. Among authors: he y. Cancer Biomark. 2019;24(1):31-42. doi: 10.3233/CBM-181229. Cancer Biomark. 2019. PMID: 30614794

7

Multi-Omics Insights into Disulfidptosis-Related Genes Reveal RPN1 as a Therapeutic Target for Liver Cancer.

He Y, Hu Y, Cheng Y, Li X, Chen C, Zhang S, He H, Cao F. He Y, et al. Among authors: he h. Biomolecules. 2024 Jun 10;14(6):677. doi: 10.3390/biom14060677. Biomolecules. 2024. PMID: 38927080 Free PMC article.

8

MiR-361-5p promotes oxygen-glucose deprivation/re-oxygenation induced neuronal injury by negatively regulating SQSTM1 in vitro.

Zeng T, Zhang S, He Y, Liu Z, Cheng Q. Zeng T, et al. Among authors: he y. Metab Brain Dis. 2021 Dec;36(8):2359-2368. doi: 10.1007/s11011-021-00845-x. Epub 2021 Sep 28. Metab Brain Dis. 2021. PMID: 34581931

9

Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.

Chen S, He Y, Huang X, Shen Y, Zou Q, Yang G, Fu L, Liu Q, Luo D. Chen S, et al. Among authors: he y. J Nanobiotechnology. 2024 Jun 19;22(1):348. doi: 10.1186/s12951-024-02612-3. J Nanobiotechnology. 2024. PMID: 38898486 Free PMC article.

10

Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver.

Jia B, Wang Y, Yu G, Cheng Y, Yang C, Cao F, He Y, Cao P, Meng X, Yu D. Jia B, et al. Among authors: he y. Biomed Pharmacother. 2019 Jul;115:108848. doi: 10.1016/j.biopha.2019.108848. Epub 2019 Apr 30. Biomed Pharmacother. 2019. PMID: 31039496 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,964 results

Search Page

Filters